Atlantis Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 1.00 M
as on 03-07-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
as on 03-07-2024
- Revenue -30.62%
(FY 2023)
- Profit -36.14%
(FY 2023)
- Ebitda 31.01%
(FY 2023)
- Net Worth 38.81%
(FY 2023)
- Total Assets -0.09%
(FY 2023)
About Atlantis Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.00 Cr.
Divya Madhwani and Pranav Madhwani serve as directors at the Company.
- CIN/LLPIN
U51109MP2016PTC035250
- Company No.
035250
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Jabalpur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Atlantis Formulations Private Limited offer?
Atlantis Formulations Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Digestive System Drugs & Medicines, Antiemetic, Antacid Drugs, Common Disease Medicines, Pharmaceutical Capsules, Anti Infective Drugs & Medicines, Malaria Medicine, Antihistamines.
Who are the key members and board of directors at Atlantis Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divya Madhwani  | Director | 20-Jan-2016 | Current |
| Pranav Madhwani | Director | 20-Jan-2016 | Current |
Financial Performance of Atlantis Formulations.
Atlantis Formulations Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.62% decrease. The company also saw a substantial fall in profitability, with a 36.14% decrease in profit. The company's net worth Soared by an impressive increase of 38.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atlantis Formulations?
In 2023, Atlantis Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Nov 2022 | ₹1.00 Cr | Open |
Others Creation Date: 12 Oct 2022 | ₹3.00 Cr | Open |
How Many Employees Work at Atlantis Formulations?
Unlock and access historical data on people associated with Atlantis Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atlantis Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atlantis Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
